Sarraf Pasha's Form 4/A amendment
AmendedCue Biopharma, Inc. (CUE) · filed Aug 28, 2026
- Accession no.
- 0002059447-26-000006
- Filed
- Aug 28, 2026, 5:05 PM ET
- Trade date
- Jul 9, 2026
- Filing delay
- 50 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 10, 2026
This filing lists 1 non-derivative transaction. It was filed 50 days after the trade.
This amendment replaces 0002059447-26-000004 (filed Jul 10, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sarraf PashaCIK 0002059447 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | AGrant or awardAcquired | +18,400 | $0.00 | $0 | 29,195 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment is being filed solely to correct an administrative calculation error in Column 4 of Table I of the original filing relating to a grant of restricted stock units ("RSUs") to the Reporting Person, which resulted in the number of securities acquired by the Reporting Person being overstated. The original filing incorrectly reported 21,800 shares; the correct amount of shares acquired is 18,400. As a result of this correction, the total amount of securities beneficially owned following the reported transaction in Column 5 has been updated to 29,195. One-third of the shares subject to the RSU vest on each of July 9, 2027, July 9, 2028 and July 9, 2029, subject to the Reporting Person's continued service with the Issuer through each such vest date.